Literature DB >> 18496475

Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression-anxiety-somatic symptoms.

Dan J Stein1, Jacqueline Muller.   

Abstract

Somatization disorder is a somatoform disorder that overlaps with a number of functional somatic syndromes and has high comorbidity with major depression and anxiety disorders. Proposals have been made for revising the category of somatoform disorders, for simplifying the criteria for somatization disorder, and for emphasizing the unitary nature of the functional somatic syndromes in future classifications. A review of the cognitive-affective neuroscience of somatization disorder and related conditions suggests that overlapping psychobiological mechanisms mediate depression, anxiety, and somatization symptoms. Particular genes and environments may contribute to determining whether symptoms are predominantly depressive, anxious, or somatic, and there are perhaps also overlaps and distinctions in the distal evolutionary mechanisms that produce these symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18496475     DOI: 10.1017/s1092852900016540

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  14 in total

1.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

Authors:  Ramadhan Oruch; Anders Lund; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2010-01-27

Review 2.  Pediatric Somatic Symptom Disorders.

Authors:  Nasuh Malas; Roberto Ortiz-Aguayo; Lisa Giles; Patricia Ibeziako
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

3.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

4.  Functional network connectivity of pain-related resting state networks in somatoform pain disorder: an exploratory fMRI study.

Authors:  Alexander Otti; Harald Guendel; Peter Henningsen; Claus Zimmer; Afra M Wohlschlaeger; Michael Noll-Hussong
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

5.  The factor structure of the Brief Symptom Inventory-18 (BSI-18) in Parkinson disease patients.

Authors:  Danielle S Abraham; Ann L Gruber-Baldini; Donna Harrington; Lisa M Shulman
Journal:  J Psychosom Res       Date:  2017-03-06       Impact factor: 3.006

6.  Altered brain activity during emotional empathy in somatoform disorder.

Authors:  Moritz de Greck; Lisa Scheidt; Annette F Bölter; Jörg Frommer; Cornelia Ulrich; Eva Stockum; Björn Enzi; Claus Tempelmann; Thilo Hoffmann; Shihui Han; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2011-10-13       Impact factor: 5.038

7.  Psychiatric symptoms in Parkinson's disease assessed with the SCL-90R self-reported questionnaire.

Authors:  Chiara Siri; Roberto Cilia; Danilo De Gaspari; Federica Villa; Stefano Goldwurm; Catalano Marco; Gianni Pezzoli; Angelo Antonini
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

8.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  The subject, its biology, and the chronic recurrent cystitis.

Authors:  Michael Noll-Hussong; Michael Autenrieth; Dan Pokorny; Simone Herberger; Dorothea Huber
Journal:  Case Rep Psychiatry       Date:  2012-04-18

10.  Frequency shifts in the anterior default mode network and the salience network in chronic pain disorder.

Authors:  Alexander Otti; Harald Guendel; Afra Wohlschläger; Claus Zimmer; Michael Noll-Hussong
Journal:  BMC Psychiatry       Date:  2013-03-13       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.